Amalgamated Bank’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,917
| Closed | -$528K | – | 3197 |
|
|
2023
Q1 | $528K | Sell |
4,917
-810
| -14% | -$87K | ﹤0.01% | 1400 |
|
|
2022
Q4 | $630K | Buy |
5,727
+775
| +16% | +$85.3K | 0.01% | 1356 |
|
|
2022
Q3 | $292K | Buy |
4,952
+298
| +6% | +$17.6K | ﹤0.01% | 1691 |
|
|
2022
Q2 | $131K | Buy |
4,654
+872
| +23% | +$24.5K | ﹤0.01% | 2064 |
|
|
2022
Q1 | $143K | Buy |
+3,782
| New | +$143K | ﹤0.01% | 2065 |
|